Skip to content
PlayLife Magazine

Zimbabwe Turns Down ‘One-Sided’ US Health Aid Deal Over Data Fears

Medical funding image
The proposed American funding would have supported programmes for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has turned down a significant American healthcare agreement worth $367m (272 million pounds) over five years because of the United States' request for confidential biological samples.

This move came to light following a official document dated December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the deal was "lopsided".

A government representative later clarified that the US was demanding access to health data for scientific study and profit while was unwilling to guarantee the benefits from future vaccines.

"We are forced to start the challenging and unfortunate task of ending our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the US had provided over $1.9bn for health programmes to Zimbabwe during the past two decades.

A medical body in Zimbabwe has appealed for more talks to find a deal agreeable to all parties so the country's vital HIV programme can proceed.

Wider Background

This development comes after a comparable case in neighbouring Kenya, where a court halted a similar health funding agreement following legal challenges were raised about the safety of Kenyans' medical information.

Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.

The agency had administered assistance for the US government, but Trump stated its spending was "inefficient" and his government was pursuing direct bilateral deals to enhance transparency and responsibility.

Based on statements, Sixteen African countries have so far agreed to similar agreements, representing more than $18.3bn of fresh investment.

Specifics of the Rejected Agreement

The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this collaboration would have delivered significant advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving HIV treatment through US-supported initiatives," the Ambassador commented.

However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".

"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, without any corresponding guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," his statement read.

"Put simply, our nation would provide the basic resources for scientific discovery with no certainty that the final treatments would be available to our citizens if a new health crisis arise."

Sovereignty and Global Health

Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending systems already set up through the global health agency.

The spokesperson cited its Pandemic Benefit-Sharing framework created to manage potential pandemics.

"This system is intended to ensure that when a nation provides its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to create them."

These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.

"We are open to further discussions with our US partners on how future collaboration could be designed in a manner that respects the independence and interests of both nations."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but suggested that negotiations need to persist given that much of the country's HIV programmes were funded by international support.

"In cases where specific concerns exist, such as those relating to data governance or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," it added.

The situation underscores the complex challenges between receiving much-needed international aid and protecting a country's data in an ever more data-driven world.

By

Joanna Warren

A UK-based lifestyle journalist with over a decade of experience covering entertainment and cultural trends across Europe.

PlayLife Magazine

Type to search articles.